Pathway-wide base editing charts chemical-genetic interactions in MAPK signaling

Scientists have developed a method called CRISPR base editor (BE) scanning to study how proteins work together in a cellular environment. This technique allows researchers to examine the interactions between various proteins within a pathway, which is particularly useful for understanding complex disease mechanisms such as those involved in cancer.

The researchers focused on a specific signaling pathway known as the RAS-RAF-MEK-ERK (MAPK) cascade, which is often targeted by cancer drugs and remains a significant therapeutic challenge.

By applying BE scanning to 22 genes within the MAPK pathway, both when they were hyperactivated or inhibited, the researchers created a comprehensive chemical-genetic map of the signaling process. This map revealed surprising insights into how drug resistance often arises in proteins that are not directly targeted by the drugs. The scientists discovered that these resistance mutations frequently occur in proteins that interact with the drug target.

This finding has implications for understanding the broader implications of drug resistance and treatment strategies.

Furthermore, the BE scanning identified previously unrecognized functional hotspots within the signaling pathway, such as an allosteric site in the KRAS N-terminus, which was not previously considered in drug design efforts. Additionally, the study revealed catalytically impaired CRAF mutants that show unexpected behaviors—these mutants confer both resistance and sensitivity to similar MEK inhibitors, highlighting the complexity of how different compounds interact with the pathway.

This discovery underscores the need for a nuanced understanding of compound interactions in drug development.

Overall, the researchers concluded that BE scanning is an effective, scalable approach for mapping the chemical-genetic interactions within cellular pathways. This method not only expands our understanding of established oncogenic pathways like MAPK but also opens new avenues for discovering novel therapeutic strategies by revealing the intricate network of interactions between proteins and potential drug targets.